drugset / Trial / NCT02768727

A Test of Neural Inertia in Humans With Xenon

NCT02768727

Phase 2 Completed 21 enrolled University of Pennsylvania
NaSingle-groupOpen-labelBasic science

Summary

The dual objectives of this study are to determine if the phenomenon of neural inertia is present in humans and to determine whether the order of neurocognitive function is invariant among anesthetic agents. This study will enroll 24 healthy volunteers, ages 20-40 years, who will receive xenon gas (concentrations ranging from 0% to 60%) delivered via inhaled route through the ENHANCER 3000.

Timeline

Start
2016-04
Primary completion
2019-12-01
Completion
2021-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Xenon Other / unclassified 60 % Inhaled

Indications